Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective-Reference-Cited by-同舟云学术

Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective

Published:2017-01-23 Issue:2 Volume:102 Page:283-289
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Anton R¹,Haas M¹,Arlett P¹,Weise M²,Balabanov P¹,Mazzaglia G¹,Prieto L¹,Keller-Stanislawski B³,Raine J⁴

Affiliation:

1. European Medicines Agency; London United Kingdom

2. Federal Institute for Drugs and Medical Devices; Bonn Germany

3. Department of Safety of Medicinal Products and Medical Devices; Paul-Ehrlich Institute, Federal Institute for Vaccines and Biomedicines; Langen Germany

4. Medicines and Healthcare Products Regulatory Agency; London United Kingdom

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference65 articles.

1. JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes;Diotti;Clin. Dev. Immunol.,2013

2. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives;Pavlovic;Ther. Adv. Neurol. Disord.,2015

3. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis;Dutta;Prog. Neurobiol.,2011

4. European Medicines Agency Transatlantic workshop on drug-related progressive multifocal leukoenchephalopathy (PML): workshop proceedings. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/09/WC500111562.pdf 2011

5. Drug-induced PML: a global agenda for a global challenge;Souza;Clin. Pharmacol. Ther.,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progressive multifocal leukoencephalopathy and spectrum of predisposing conditions: a 20-year retrospective cohort study in a tertiary center in São Paulo, Brazil;Neurological Sciences;2024-07-15

2. Integrins as Drug Targets in Vascular and Related Diseases;International Journal of Drug Discovery and Pharmacology;2024-06-21

3. Infektionen und Multiple Sklerose;Fortschritte der Neurologie · Psychiatrie;2024-05-08

4. The Efficacy of Ivermectin and Metronidazole vs. Standard Treatment Protocols on Outcomes of COVID-19 in Hospitalized Patients: A Triple-Blinded Randomized Controlled Trial;ARCH CLIN INFECT DIS;2022

5. Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline;Practical Neurology;2022-07-21